Acceleron has entered into several corporate alliances with established biopharmaceutical companies, each of which is a committed leader in the fields for which we intend to develop and commercialize our products. We are proud to work with partners who share our vision of developing ground-breaking therapies.
To date, our company has raised over $170 million in funding through our partnerships. These collaborations will enable us to advance our lead products through development and to retain a substantial operational role and financial return. Our strategy enables us to continue investing in our research pipeline and expand our portfolio of novel therapies.